Aviva’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-134,004
Closed -$2.11M 1053
2022
Q2
$2.11M Hold
134,004
0.01% 774
2022
Q1
$2.07M Hold
134,004
0.01% 837
2021
Q4
$1.13M Sell
134,004
-24,543
-15% -$211K ﹤0.01% 923
2021
Q3
$1.43M Buy
158,547
+66,783
+73% +$541K 0.01% 903
2021
Q2
$912K Buy
+91,764
New +$776K ﹤0.01% 813
2015
Q1
Sell
-59,569
Closed -$988K 828
2014
Q4
$988K Buy
59,569
+270
+0.5% +$5.7K 0.01% 784
2014
Q3
$1.93M Sell
59,299
-50
-0.1% -$1.7K 0.02% 731
2014
Q2
$2.07M Sell
59,349
-160
-0.3% -$5.25K 0.02% 717
2014
Q1
$1.89M Buy
59,509
+3,240
+6% +$90.1K 0.02% 715
2013
Q4
$1.43M Buy
56,269
+1,720
+3% +$41.2K 0.01% 736
2013
Q3
$1.17M Buy
54,549
+9,827
+22% +$202K 0.01% 763
2013
Q2
$866K Buy
+44,722
New +$976K 0.01% 779

Other funds holding PTEN

Aviva's PTEN Position: Q3 2022 in Review

Aviva sold out of Patterson-UTI (PTEN) in Q3 2022, closing a stake of 134,004 shares — an estimated $2.11M sold.

Aviva first reported a position in PTEN in Q2 2013 and held it in 12 quarters. The position peaked at $2.11M in Q2 2022. 285 funds tracked by Wall St. Rank hold PTEN as of Q3 2022.

  • Aviva reported no remaining Patterson-UTI position as of Q3 2022 after selling out during the quarter.
  • Aviva sold 134,004 Patterson-UTI shares in Q3 2022, an estimated $2.11M.
  • Aviva first reported a position in Patterson-UTI in Q2 2013 and held it in 12 quarters.
  • Aviva's Patterson-UTI position peaked at $2.11M in Q2 2022.
  • 285 funds tracked by Wall St. Rank held Patterson-UTI as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.